Pfizer

News

Close-up of the fag of Germany against a blue sky.

Germany confirms booster COVID jabs will start in September

Germany's health ministry has said it will start offering booster COVID-19 vaccines to vulnerable people from next month, amid concerns about rising cases of the delta variant of the corona

News

Resourceful or risky-The UKs controversial COVID-19 vaccine strategy

Study finds jabs cut severe variant COVID disease after one ...

A real-world study carried out in Canada has found that COVID-19 vaccines from AstraZeneca, Pfizer/BioNTech and Moderna reduce the chances of being hospitalised or dying from variants of co

News

Pfizer puts up $1bn to buy into Arvinas breast cancer progra...

Pfizer has pledged a whopping $1 billion upfront for rights to an Arvinas drug for breast cancer from its protein degrader platform, which harnesses cells' natural protein-denaturing machin

News

FDA okays Merck's would-be Prevnar rival Vaxneuvance

The FDA has approved a new pneumococcal vaccine from Merck & Co, just over a month after Pfizer got a green light for a new version of its market leading Prevnar shot.

News

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background

Shot in the arm for Affinivax as it challenges Pfizer's Prev...

Already facing one rival to its blockbuster pneumococcal vaccine Prevnar, Pfizer could have another to contend with, after Affinivax reported positive phase 2 results with its ASP3772 candi

News

Eyeing delta surge, Pfizer will file COVID-19 booster next m...

With the COVID-19 delta variant becoming the dominant strain circulating in the US, Pfizer and BioNTech have said they will ask the FDA and other regulators to approve a third dose of their Comi

Germany confirms booster COVID jabs will start in September

Study finds jabs cut severe variant COVID disease after one ...

Pfizer puts up $1bn to buy into Arvinas breast cancer progra...

FDA okays Merck's would-be Prevnar rival Vaxneuvance

Shot in the arm for Affinivax as it challenges Pfizer's Prev...

Eyeing delta surge, Pfizer will file COVID-19 booster next m...

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

Pfizer

Editor's Picks